Week 3/4 - A - Lung cancer - Risk factors/Presentation/DIagnosis/Staging/Treatment (NSCLC and SCLC), targeted therapies Flashcards

1
Q

What are the most common cancers in the UK?

A

The most common cancers in the UK are prostate, breast, lung and colorectal cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Is there a difference between the incidence and prevalence of lung cancer?

A

The incidence of lung cancer is very high as many new cases arrive daily (roughly 100 new cases daily in UK) The prevalence of lung cancer is actually quite low due to most cases presenting quite late and majority of lung cancers are incurable (90%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the risk factors for lung cancer?

A

Cigarette smoking or passive smoking Family history Radon gas Asbestos exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is a paraneoplastic syndrome?

A

A paraneoplastic syndrome is a set of signs and symptoms that are consequence of cancer in the body but not due to the local or distant spread of the tumour cells. It is specifically due to the production of chemical signalling molecules (hormones or cytokines) by the tumour cells or an immune response to the tumour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the common presenting symptoms in patients with lung cancer? (try and list the most common symptoms first)

A

* Persistent cough for longer than three weeks * Haemoptysis * Dyspnoea * Chest pain * Weight losss * Recurrent or slowly resolving pneumonia * Unexplained tiredness or lack of energy * A hoarse voice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the two images Image on the right- man who presented to his GP with a three week history of haemoptysis

A

Left image - bronchoscope at lower trachea looking directly at the carina - healthy pale pink mucosa and underlying cartilage rings Right image - mucosa is very red, shrowing fresh blood from the tumour which is ulcerating throug the surface of the bronchii. Cytology brush positioned just above the tumour

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What happens to the lung volume in the affected lung with cancer?

A

In lung cancer, the larger the tumour gets, the smaller the lung volume appears to be - visible on CXR - this is because the tumour obstructs the proximal branches of the bronchial tree therefore air cannot reach the part of the lung beyond this to expand Right lung smaller than left (image)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

We have discussed the presentation of the primary tumour (cough, haemoptysis, dyspnoea, chest pain, weight loss, recurrent/slowly resolving pneumonia. lethargy, hoarse voice) Lets discuss the local invasion, metastes and non-metastatic (paraneoplastic) presentations What are the neighboring structures that are locally invaded by lung cancers?

A

LOCAL INVASION * Recurrent laryngeal nerve * Pericardium * Oeosphagus * Brachial plexus * Pleural cavity * Superior vena cava

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

LOCAL INVASION * Recurrent laryngeal nerve * Pericardium * Oeosphagus * Brachial plexus * Pleural cavity * Superior vena cava What is the course of the recurrent laryngeal nerves? What symptom does it result in?

A

RRLN - branches off the vagus nerve & hooks under the right subclavian artery LRLN - branches off the vagus nerve & hooks under the arch of the aorta They both travel upwards to supply the intrinsic muscles of the larynx Invasion of the nerve results in nerve palsy causing hoarseness (due to reduced mobility of the vocal cords)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the symptoms caused by local invasion of the pericardium and oesophagus?

A

Pericardium invasion - breathlessness, atrial fibrillation and pericardial effusion Oesophageal invasion can present as dysphagia (difficulty swallowing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In patient’s who present with a lung tumour in the apex, what can this cause? What is the term for a apex tumour of the lung known as?

A

Apex tumour of the lung is also known as a pancoast tumour * Can invade the brachial plexus causing weakness and/or atrophy of the intrinsic muscles of the hand, and paraesthesias and/or pain in C8/T1 distribution. * Can causes ipsilateral Horner’s syndrome by invading the sympathetic chain (miosis, ptosis, anhidrosis and appraent enopthalmos) * Can also cause recurrent laryngeal nerve palsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the cough that may be seen in patients with a recurrent laryngeal nerve palsy known as?

A

This is a bovine cough - a non-explosive cough caused by somebody unable to close their glottis (vocal cords cannot fully adduct due to nerve palsy) during coughing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What happens when a lung tumour locally invades the pleural cavity?

A

Invasion of the pleural cavity can cause pleural fluid to accumulate - cause symptoms of breathlessness Requires draining usually

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the symptoms/signs of suprerior vena cava obstruction in local lung cancer invasion?

A

Obstruction of the SVC is an oncological emergency Local invasion of the SVC obstructs drainage of blood from the arms and head. The patient may describe puffy eyelids and a headache. There is also superficial distension of the veins - JVP, abdomen and thorax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How would you treat the SVCO if cause by extrinsic malignant compression?

A

Give O2 if needed Give dexamethasone to reduce inflammation Stenting provides the most rapid relief of symptoms but the underlying tumour must be treated Treat underlying cancer with radiotherapy or chemotherapy depending on sensitivities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why can you also get rib erosion in lung cancer?

A

The cancer can locally invade into the chest wall and therefore through the ribs destorying part of it and causing pain (bone pain often worse at night)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are common sites for lung cancer metastases? (most common come under the acronym BLAB)

A

Brain Liver Adrenals Bone Also skin and lung

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Metastases from the lung most commonly are brain, liver, adrenal or bone How do patients with brain mets present?

A

Cerebral mets usually have an insidious onset * Headaches worse in the morning * Weakness * Visual disturbance * Ataxia * Nausea and vomiting * Fits can occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Liver mets can cause an obstructive jaundive type picture if obstructing the biliary drainage State what is scene on the CT

A

Can see the irregular outline of liver mets Also incidental finding of a smooth growth in the right kidney - benign cyst

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pic just showing adrenal metastases from lung cancer What are the presenting symptoms of bone cancer metastes from the lung? What is increased in the blood?

A

Pain or pathological fractures can result from bone metastases. The axial skeleton and proximal long bones are most frequently involved May cause hypercalcaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What investigation would you do in new bone pain in someone with suspected bone metastasis?

A

Investigation - CXR and radionuclide bone scan (Tc-99m)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

We have discussed risk factors, symptoms of primary tumour/local invasion/metastases Now we discuss the non-metastatic presentation - paraneoplastic syndorme What are other causes of finger clubbing?

A

* Cyanotic heart disease * Lung disease (hypoxia, cancer, CF, IPF) * UC/Crohns * Biliary cirrhosis * Birth defect * Infective endocarditis * Neoplasm * GI malabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is hypertrophic pulmonary oesteoarthropathy characterised by?

A

HPOA is characterised by a triad of finger clubbing, symmetrical arthtitis and periosteal bone formation causing periostitis Symptoms of pain and tenderness of the long bones near the adjacent joints are due to elevation of the periosteum away from the bone surface. This bone scan shows increased activity, particularly in the distal part of the tibia and fibula.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What causes the hypercalcaemia in non-metastatic lung cancer? Which type of lung cancer is this most common in?

A

Hypercalcaemia can result from the tumour producing a substance which mimics the effects of parathyroid hormone - this substance is known as a Parathyroid hormone related protein (PTHrP) - it is occasionally secreted by cancer cells - eg lung cancer - most commonly squamous cell carcinoma of the lung PTH increases resoprtion of bone causing increase calcium

25
Q

What are the signs/symptoms of hypercalcaemia? (stones, bones, groans, thrones, psychic overtones)

A

Stones - renal/biliary calculi Bones - bone pain due to bone resorption Groans - abdo pain, contipation, nausea Thrones - polydipsia / polyuria Psychiatric overtones - confusion, depression, anxiety, reduced GCS Also cardiac arrhythmia

26
Q

What is the treatment of hypercalcaemia?

A

Initial treatment is rehydration If this does not work, then prescribe IV biphosphonates (prevent bone resorption) Calcitonin can be given - more rapid but short term effect

27
Q

PTHrP secreting tumours are linked to squamous cell carcinoma of the lung Name three paraneoplastic syndromes that are related to small cell carcinoma of the lung?

A

Small cell lung cancer * Syndrome of inappropriate ADH secretion (SIADH) - ADH secreting tumour * Cushing’s disease - ACTH secreting tumour - * Lambert-Eaton myasthenic syndrome - antibody to the voltage gated Ca2+ channlels on the pre-synaptic membrane

28
Q

What is the treatment of the SIADH?

A

Treat the cause of the condition * 1st line - Fluid restriction and consider saline * 2nd line Vasopressor receptor antagonsist can be used eg the vaptans (tolvaptan) or saline+/- frusomide * Demeclocycline may be required Vasopressin is aka anti-diuretic hormone

29
Q

How does demeclocyline work for SIADH?

A

It is a tetracycline antibitoic but can cause nephorgenic diabetes insipidus (kidneys do not respond to ADH therefore increasing water lost in urine)

30
Q

As previously stated, the greatest risk factor for lung cancer is cigarette smoking followed by passive smoking (biggest risk factor for all patients) What type of lung cancer is associated with non smoking? What lung cancers are central and which are peripheral usually?

A

If a non-smoker presents with lung cancer - think adenocarcinoma - usually located peripherally in the lung (large cell also found peripherally) Small cell and squamous cell carcinomas are usually found centrally

31
Q

Making the diagnosis of lung cancer - lots of possible tests Why would sputum cytology be carried out?

A

Sputum cytology isn’t normally carried out because whether it is positive or negative the patient will still recieve a bronchoscopy Only use sputum cytology for investigation in people with suspected lung cancer who have centrally placed nodules or masses and who decline or cannot tolerate bronchoscopy or other invasive tests.

32
Q

A standard PA chest x-ray is an inexpensive and simple initial step to evaluate cough, chest pain, and/or haemoptysis. What is carried out after an xray and must be carried out before any biopsy procedure is undertaken?

A

Perform contrast-enhanced CT of the chest, liver adrenals and lower neck before any biopsy procedure.(lower neck, thorax and upper abdomen)

33
Q

The history, examination, imaging and blood tests are all important BUT we need tissue to make the diagnosis with certainty. This slide lists the common ways to make the diagnosis. What investigation is used in people with central or peripheral tumours on CT?

A

Tissue is sampled from bronchoscopy where possible - only useful in central lesions - cannot pass bronchscope into dividisons smaller than the scope in the peripheries.. Transthoracic needle aspiration biopsy, typically using CT guidance, is used to biopsy suspicious peripheral pulmonary lesions that are not accessible with bronchoscopy.

34
Q

What imaging is offered to all patients potentially receiving treatment with curative intent to fully stage the cancer? (usually online NSCL , small cell cant really be cured)

A

Ensure that all people with lung cancer who could potentially have treatment with curative intent are offered positron-emission tomography CT (PET‑CT) before treatment

35
Q

When wanting to assess the intrathoracic lymph nodes, what imaging and diagnosis technique is used to accurately diagnosis the tumour? (same imaging as used for patients potentially receiving curative intent treatment)

A

Assessing intrathoracic nodes PET-CT is carried out followed by Endobranchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) - ultrasound guides scope to target and lymph nodes and allow needle aspiration of the nodes

36
Q

Bronchoscopy - central tumours CT guided transbronchial needle aspiration - peripheral tumours Lymph node aspirate - EBUS-TBNA What is carried out if the patient has a pleural effusion? (1st and 2nd line)

A

Many patients present with a pleural effusion, and US guided thoracentesis is indicated, followed by thoracoscopy, if fluid is negative. Direct visualisation of the pleura using thoracoscopy has a very high degree of specificity for the diagnosis of pleural effusion.

37
Q

The surgeon will need to be certain that the cancer can be completely removed by an operation so the pre-operative staging amounts to a thorough search for evidence of metastases or local invasion. E.g, if a pneumectomy is being carried out, how much disease free bronchus is required and why?

A

If a pneumectomy is being carried out, there must be at least 2cm disease free bronchus to close off the hole. If the tumour encroaches within 2cm of the carina, it will be impossible to remove it without leaving a hole in the side of the trachea. In pic - inoperable (carina invaded)

38
Q

What are the factors used for giving a prognosis prior to treatment of lung cancer?

A

Tumour stage and Tumour histological subtype

39
Q

Which type of lung cancers have the worst prognosis?

A

Small cell lung cancer has the worst prognosis Large cell lung cancer has a worse prognosis than squamous and adenocarcinoma

40
Q

We have now discussed risk factors, presenting symptoms (primary tumour, local invasion, mets, paraneoplastic), diagnosis and how staging is carried out (PET-CT / EBUS-TBNA (lymph nodes)) Now we look at the staging classification TNM staging is used to classify the lung tumours into stages I-IV * Try and describe the T (primary tumour) section of the TNM for lung cancer as best you can?

A

* TX - cancer cells present in sputum/pleural fluid but no other evidence of tumour * T0 - no cancer evident * T1 - cancer 3cm and >2cm distal to carina or pleural involvement * T3 - more than one nodules in same lobe of the lung, and local invasion. 7cm diameter * T4 - multiple nodules in another lobe or invaded carina, heart, malignant effusion

41
Q

Try and describe the N and M (regional nodes and distant metastases) section of the TNM for lung cancer as best you can?

A

N0 - none involved N1 - peribronchial and/or ipsilateral hilum N2 - Ipsilateral mediastium or subcarinal N3 - contralateral mediastinum or hilum or scalene or supraclavicular M0 - no metastases M1 - nodules in other lung M1b/c - distant mets present

42
Q

The TNM staging is used to classify the tumour into 4 stages Try and describe the 4 stages

A

Stage I: The cancer is located only in one lung and has not spread to any lymph nodes. (T1/2, NO, MO) Stage II: The cancer is in one lung and nearby lymph nodes. (T1/2, N1, MO) Stage III: Cancer is found in the lung and in the lymph nodes in the middle of the chest, aka locally advanced disease. * If only to ipsilateral lymph nodes - stage IIIA. * If to contralateral lymph nodes or above collar bone - stage IIIB Stage IV: Advanced disease. Cancer has spread to both lungs, to fluid in the area around the lungs, or to another part of the body, such as the liver or other organs.

43
Q

What is the treatment of choice for small cell lung cancers?

A

Small cell carcinomas of the lung are chemosensitive with rapidly emerging resistance In limited disease radiotherapy is given in adjunct and it is considered in extensive disease Surgery is offered to very early presenting patients only

44
Q

What is the prophylactic treatment given to SCLC patients with limited or extensive disease?

A

Prophylactic cranial irradiation is given due to the high occurrence of cerebral metastases

45
Q

How does immunohistochemistry help to differentiate between cancers in small biopsies?

A

Immunohistochemistry involves using antibodies that target specific antigens present in different types of cancers to allow you to see which type of cancer it is Ie squamous and adenocarcinomas will have different proteins expressed on their surfaces

46
Q

What cell markers are expressed that help differentiate between adenocarcinomas and squamous cell carcinomas of the lung?

A

Adenocarcinomas express thyroid transcription factor 1 (TTF1) Squamous cell carcinomas express nuclear antigen p63 and molecular wt cytokeratins

47
Q

NSCLC treatment aims for curative intent if the cancer is low stage What should all patients undergo before receiving treatment with curative intent?

A

All patients should undergo lung function tests (eg spirometry) when being considered for treatment with curative intent

48
Q

What is the 1st option for treatment with curative intent? (usually stages 1-3) What is given as an adjunct?

A

For people with NSCLC who are well enough and for whom treatment with curative intent is suitable, offer surgery - preferably lobectomy Adjuvant chemotherapy and/or radiotherapy may be offered to these patients

49
Q

What are the two different choices for carrying out the lobectomy in the patient?

A

Firstly removal of the lung lobe, lung segment or lung itself is decided for surgery Access to the chest is achieved through a thoracotomy (open surgery) or minimally invasive techniques (e.g., video-assisted thoracic surgery - VATS).

50
Q

Why is VATS becoming more commonly used? (thorascopic surgery aka minimally invasive surgery)

A

The patients require shorter hospitalisations, are associated with less postoperative pain, and may be safer

51
Q

In patients who decline surgery or whom surgery is contraindicated, what is the treatment option in patients whens till aiming for curative intent? (usually stages 1-3)

A

In patients for whom surgery is declined or contraindicated, they should be offered * Radical radiotherapy or * Stereotactic ablative radiotherpy (SABR) These are given with adjuvant chemotherapy

52
Q

What is the difference between radical radiotherapy and stereotatic ablation radiotherapy?

A

Radical radiotherapy is an intense course of high dose radiation aimed at curing the cancer - collateral damage SABR however uses many more, less powerful beams so that the collateral damage due to the ionising radiation is less however the total dose is higher

53
Q

What is the main treatment option for patients with lung cancer that is stage 4? (that has spread contralaterally or metastasised)

A

In stage IV lung cancer, chemotherapy is typically the main treatment. In stage IV patients, radiation is used only for palliation of symptoms.

54
Q

In NSLC, there can be different molecular abnormalities leading to the development of the cancer (ie different oncogenes and tumour suppressor genes can become mutated) and there are treatment options that look at targeting these mutations Targeted treatments and immunotherapy treatments have become more available recently What stages of cancer are these therapies usually used in?

A

Targeted therapies and immunotherapies are becoming used 1st line or in combination with chemotherapy for Stage IIIB or Stage IV NSCLC

55
Q

Specific genetic mutations increasing tumour activity are being tested for in lung cancer and treatments are becoming available Eg mutations in EGFR, ALK1 and ROS1 What type of lung cancer do these mutations usually occur in ? Where in the lung are these cancers often found?

A

EGFR, ALK1 and ROS1 mutations (if occurring) usually occur in adenocarcinomas promoting cancer growth Adenocarcinomas are usually found in the periphery of the lung

56
Q

Unlike chemotherapy drugs, which cannot tell the difference between normal cells and cancer cells, targeted therapies are designed specifically to attack cancer cells by attaching to or blocking targets that appear on the surfaces of those cells. People who have advanced lung cancer with certain molecular biomarkers may receive treatment with a targeted drug alone or in combination with chemotherapy What are the treatment options for * EGFR positive mutations? * ALK1 positive mutations? * ROS1 positive mutations?

A

EGFR positive mutations - use a tyrosine kinase inhibitor eg erlotinib ALK1 positive mutations - targeted treatment eg crizotinib ROS1 positive mutations - also crizotinib

57
Q

Just as genetic mutations can be present in lung cancer and can be targeted (EGFR, ALK1, ROS1 in adenocarcinoma), proteins that are expressed in advanced cancers that affct our immune response can be targeted Name the protein and how it works?

A

PD-L1 (programmed death ligand 1) (expressed in some NSCLC) binds to the PD receptor (programmed death) on T lymphoctyes inactivating the cytotoxic immune response Targeted therapy can inhibit this effect and enhance immune killing of the tumour

58
Q

Name a treatment option for targeting PD-L1 positive cancers?

A

Pembrolizumab is a type of immunotherapy. It stimulates the body’s immune system to fight cancer cells. Pembrolizumab targets and blocks a protein called PD-1 on the surface of certain immune cells called T-cells. Blocking PD-L1 triggers the T-cells to find and kill cancer cells.